Lishomwa (Lish) Ndhlovu MD, PhD is a Professor of Immunology in Medicine in the Division of Infectious Diseases at Weill Cornell Medicine. The thrust of his research program is confronting the challenges of HIV and aging and is developing specific strategies to prevent, slow or eliminate complications associated with HIV. His team combines immunology, virology and epigenetic methods exploring molecular mechanism of HIV pathogenesis and persistence through pre-clinical and clinical investigations and has expanded towards finding an HIV cure. He has also become increasingly involved in bringing the same urgency and focus to the COVID-19 pandemic and exploits immuno-epigenetic approaches to resolve molecular mechanisms regulating SARS-CoV-2 infection across tissues and cell types in people with and without HIV. His lab is largely supported by individual and consortia grants from the NIH. He is a member of the International Neuro-HIV Cure Consortium and Co-leader of the $26.5 million NIH - funded Martin Delaney Collaboratory for HIV Cure “HOPE” and NIDA funded U01-SCORCH program documenting single cell opioid responses in the brain in the setting of HIV. Heis an elected Fellow of the American Academy of Microbiology and serves as Co-Editor in Chief of the journal, AIDS Research and Human Retroviruses.
